Literature DB >> 33140923

Withdrawing Approval of Makena - A Proposal from the FDA Center for Drug Evaluation and Research.

Christina Y Chang1, Christine P Nguyen1, Barbara Wesley1, Jia Guo1, Laura Lee Johnson1, Hylton V Joffe1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 33140923     DOI： 10.1056/NEJMp2031055

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.

Authors:  Caitlin C Murphy; Piera M Cirillo; Nickilou Y Krigbaum; Barbara A Cohn
Journal:  Am J Obstet Gynecol       Date:  2021-11-09       Impact factor: 10.693

2.  Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval.

Authors:  Rachel E Sachs; Kyle A Gavulic; Julie M Donohue; Stacie B Dusetzina
Journal:  JAMA Health Forum       Date:  2021-10-08

3.  Regulatory approval for COVID-19 across the globe.

Authors:  Vidya Mahalmani; T Pugazhenthan; Niti Mittal; Shoban Babu Varthya; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

4.  17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Abdulaali R Almutairi; Hadir I Aljohani; Nouf S Al-Fadel
Journal:  Front Med (Lausanne)       Date:  2021-12-01

5.  Preterm Birth Therapies to Target Inflammation.

Authors:  Ioannis Pavlidis; Sarah J Stock
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

Review 6.  Landscape of Preterm Birth Therapeutics and a Path Forward.

Authors:  Brahm Seymour Coler; Oksana Shynlova; Adam Boros-Rausch; Stephen Lye; Stephen McCartney; Kelycia B Leimert; Wendy Xu; Sylvain Chemtob; David Olson; Miranda Li; Emily Huebner; Anna Curtin; Alisa Kachikis; Leah Savitsky; Jonathan W Paul; Roger Smith; Kristina M Adams Waldorf
Journal:  J Clin Med       Date:  2021-06-29       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.